High‐dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment‐related mortality in patients with multiple myeloma: results of a randomised study
暂无分享,去创建一个
U. Steidl | G. Kobbe | R. Fenk | R. Haas | A. Huenerlituerkoglu | C. Aul | M. Kropff | A. Heyll | B. Hildebrandt | U. Steidl | P. Schneider | C. Aul | Ali-Nuri Huenerlituerkoglu | Barbara Hildebrandt | Axel Heyll